Original Article
Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis
Eficacia de elbasvir/grazoprevir en la infección por hepatitis C crónica reciente G1/G4 en pacientes coinfectados por el VIH/VHC con fibrosis leve
Read
72
Timeswas read the article
27
Total PDF
45
Total HTML
0
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 March | 5 | 1 | 0 | 6 |
| 2023 February | 0 | 0 | 0 | 0 |
| 2023 January | 0 | 0 | 0 | 0 |
| 2022 December | 0 | 0 | 0 | 0 |
| 2022 November | 3 | 3 | 0 | 6 |
| 2022 October | 5 | 5 | 0 | 10 |
| 2022 September | 4 | 4 | 0 | 8 |
| 2022 August | 5 | 7 | 0 | 12 |
| 2022 July | 1 | 1 | 0 | 2 |
| 2022 June | 1 | 2 | 0 | 3 |
| 2022 May | 1 | 0 | 0 | 1 |
| 2022 April | 4 | 0 | 0 | 4 |
| 2022 March | 0 | 0 | 0 | 0 |
| 2022 February | 0 | 0 | 0 | 0 |
| 2022 January | 0 | 0 | 0 | 0 |
| 2021 December | 0 | 0 | 0 | 0 |
| 2021 November | 0 | 2 | 0 | 2 |
| 2021 October | 0 | 0 | 0 | 0 |
| 2021 September | 0 | 0 | 0 | 0 |
| 2021 August | 0 | 0 | 0 | 0 |
| 2021 July | 1 | 0 | 0 | 1 |
| 2021 June | 3 | 0 | 0 | 3 |
| 2021 May | 0 | 0 | 0 | 0 |
| 2021 April | 2 | 0 | 0 | 2 |
| 2021 March | 1 | 2 | 0 | 3 |
| 2021 February | 9 | 0 | 0 | 9 |
| 2021 January | 0 | 0 | 0 | 0 |
| 2020 December | 0 | 0 | 0 | 0 |
| 2020 November | 0 | 0 | 0 | 0 |
| 2020 October | 0 | 0 | 0 | 0 |
Show all
